JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Edit Your Profile

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY Journal

publication venue for

Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study. 28:690-698. 2018
Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder. 27:250-257. 2017
Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms. 27:38-42. 2017
Technological Considerations for the Delivery of Real-Time Child Telemental Healthcare. 26:192-197. 2016
The Case for Telemental Health for Improving the Accessibility and Quality of Children's Mental Health Services. 26:186-191. 2016
Using Synchronous Videoconferencing to Deliver Family-Based Mental Healthcare. 26:229-234. 2016
Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School". 2016
The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. 26:154-163. 2016
A Pilot Study of Stimulant Medication for Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) Who Are Parents of Adolescents with ADHD: The Acute Effects of Stimulant Medication on Observed Parent-Adolescent Interactions. 24:582-585. 2014
Concordance Between Parent and Physician Medication Histories for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. 24:269-274. 2014
A Comparison of Atomoxetine Administered as Once Versus Twice Daily Dosing on the School and Home Functioning of Children with Attention-Deficit/Hyperactivity Disorder. 21:21-32. 2011
Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder. 19:539-545. 2009
Effects of Clonidine and Methylphenidate on Family Quality of Life in Attention-Deficit/Hyperactivity Disorder. 19:511-517. 2009
Dopamine-Related Genotypes and the Dose-Response Effect of Methylphenidate on Eating in Attention-Deficit/Hyperactivity Disorder Youths. 19:127-136. 2009
The Efficacy and Tolerability of Methylphenidate and Behavior Modification in Children with Attention-Deficit/Hyperactivity Disorder and Severe Mood Dysregulation. 18:573-588. 2008
Unexpected effects of methylphenidate in attention-deficit/hyperactivity disorder reflect decreases in core/secondary symptoms and physical complaints common to all children. 18:237-247. 2008
Latino versus Caucasian response to atomoxetine in attention-deficit/hyperactivity disorder. 18:44-53. 2008
An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder. 15:947-955. 2005
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. 13:123-136.
TREATMENT OF PARENTING BEHAVIOR WITH A PSYCHOSTIMULANT - A CASE-STUDY OF AN ADULT WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER. 4:63-69.
Dexmethylphenidate Extended Release-Associated Orofacial Dyskinesia in an Adolescent with Autism Spectrum Disorder After Prolonged Use 2018
Pharmacotherapy of adolescent substance use disorders: A review of the literature 2005
Future Directions in the Use of Telemental Health to Improve the Accessibility and Quality of Children's Mental Health Services 2016

category

PEDIATRICS Category
PHARMACOLOGY & PHARMACY Category
PSYCHIATRY Category

International Standard Serial Number (ISSN)

1044-5463

Electronic International Standard Serial Number (EISSN)

1557-8992

journal abbreviation

J CHILD ADOL PSYCHOP